Product
BYDUREON
1 clinical trial
3 indications
Indication
Type 2 Diabetes MellitusIndication
chronic kidney diseaseIndication
Left Ventricular Diastolic DysfunctionClinical trial
MB001-067 A PROSPECTIVE, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, RANDOMIZED TRIAL OF EXTENDED RELEASE EXENATIDE VERSUS PLACEBO (COHORT A) AND A PROSPECTIVE, SINGLE GROUP, OPEN-LABEL, BLINDED OUTCOME TRIAL OF EXTENDED RELEASE EXENATIDE (COHORT B) IN DIABETIC PATIENTS WITH TYPE 4 CARDIORENAL SYNDROME (EXTEND-CRS TRIAL) AMENDMENT 3Status: Completed, Estimated PCD: 2019-12-01